Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Mon 365 Vancomycin dosing and monitoring in children: compliance with guidelines in a Belgian teaching hospital
Pieter De Cock, (Belgium), E Haegeman, N Goerlandt, P Vanhaesebrouck, V Stove, A Verstraete,
P Schelstraete, H Robays
Mon 366 The relaxant effect of hydrogen sulfide is potentiated while that of acetylcholine is not altered in
pulmonary and mesenteric arteries isolated from streptozotocin-induced diabetic rats
Merve Denizalti, (Turkey), TE Bozkurt, I Sahin-Erdemli, N Abacioglu
Mon 367 Bisphosphonate-related osteonecrosis of the jaw (BONJ)
G Dimosiari, Konstantinos Imprialos, (Greece), M Mironidou-Tzouveleki
Mon 368 CYP2D6 and CYP2C19: a comparison of direct versus predicted phenotyping in a South African
population
Tyren Dodgen, (South Africa), D Cromarty, H Fickl, M Pepper
Mon 369 Thyroxine medication and CYP 3A4 activity as measured by the urinary 6β-hydroxycortisol/cortisol
ratio: a pilot study
Josef Donnerer, (Austria), J-P Siest, E Beubler
Mon 370 Statins consumption in the Republic of Croatia in 2005, 2006, 2007 and 2008
Pero Draganic, (Croatia), S Zezelic, V Macolic-Sairinic, S Tomic
Mon 371 Usage of and attitudes towards the drug-drug interaction database SFINX – a questionnaire study within
Sweden
Birgit Eiermann, (Sweden), M Andersson, M-L Ovesjö, P Bastholm, A Veg, M Edlert, Y Böttiger
Mon 372 Comparative efficacy and bioavailability of different praziquantel brands
Naglaa El-Lakkany, (Egypt), S Seif el-Din, AN Sabra, M Ibrahim, S Botros
Mon 373 Resistance of Escherichia coli and Klebsiella pneumoniae isolates in three tertiary intensive care units:
A result of insufficient employment of infection control measures or inadequate antibiotic consumption?
Viktorija Erdeljic, (Croatia), I Francetic, Z Bosnjak, A Budimir, S Kalenic, L Bielen, R Likic,
K Makar-Ausperger
Mon 374 Does missense mutation in the SMPD3 gene increase the risk of pulmonary hypertension?
Lucía Escolano, (Spain), MA Nieto, L Moreno, A Cogolludo, A Roman, JL Alvarez-Sala, F Perez-Vizcaino
Mon 375 Distribution of methylphenidate and ritalinic acid in oral fluid
Magi Farre, (Spain), R Pardo, E Marchei, O Garcia-Algar, M Pellegrini, R Pacifici, S Pichini
Mon 376 Central nervous system pathology during pregnancy. Study of 25 clinical cases using an
evidence-based approach
Isabel Vitória Figueiredo, (Portugal), AC Rama, O Isabel, F Tavares, T Santos, F Fernández-Llimós,
MM Castel-Branco, A Cabral, M Caramona,
Mon 377 Adverse drug reactions in infants and children
Houda Filali, (Morocco), A Elgharbi, F Hakkou
Mon 378 Causes of therapeutic errors in older adults
Houda Filali, (Morocco), H Elkarimi, D Mzah, A Miftah, F Hakkou
Mon 379 CANCELLED
Mon 380 Contribution of CYP2C8 to the metabolism of montelukast in vitro
Anne Filppula, (Finland), J Laitila, PJ Neuvonen, JT Backman
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 189